Navigation Links
Drug Delivery Technology Market worth $224.2 Billion By 2017

DALLAS, April 22, 2013 /PRNewswire/ --

The "Drug Delivery Technology Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.


• 118 market data tables

• 29 figures

• 316 pages and an in-depth Table of Content on "Drug Delivery Technology Market"

Early buyers will receive 10% customization on this report.

This report studies the global drug delivery market, with forecast to 2017.

The Drug Delivery Market is divided into Nine Segments, namely:

1. Oral

2. Pulmonary

3. Transdermal

4. Injectable

5. Ocular

6. Nasal

7. Topical

8. Implantable, and

9. Transmucosal Drug Delivery.

Oral Drug Delivery is the largest segment, while pulmonary drug delivery is the fastest growing segment of the global drug delivery market.

Controlled release, dry powder inhalers, transdermal patches, needle-free injectors, auto and pen injectors, and buccal transmucosal tablets are some of the commonly adopted drug delivery technologies. The use of implantable devices for the drug delivery is also on a rise.

The global drug delivery market was worth $142.5 billion in the year 2012. The market will grow at a healthy pace in the next five years due to the rising incidence of chronic diseases such as cardiovascular diseases, diabetes and cancer, growing focus on pediatric and geriatric patients, growing demand for self administration and home healthcare devices, and patent expiries of certain blockbuster drugs.

Strategic collaborations, home care drug delivery devices, and expanding applications of drug delivery into niche therapeutic areas represent vast opportunities for major shareholders of this market. With the growing number of elderly persons, the demand for home care drug delivery devices is also on the rise.

Striking right partnership deal and enhancing the bioavailability of drugs are key burning issues in this market. In spite of a large number of strategic collaborations taking place every year, pharmaceutical and biotechnology companies are facing problems in finding a the right drug delivery partner. Considering this need, a number of national and international conferences are organized by various associations and organizations to facilitate drug delivery partnerships.

North America is the largest market for drug delivery, followed by Europe and Asia. North America and Europe has a well-established pharmaceutical industry, which has stimulated the growth of the drug delivery technology market in these regions. The Asian market is expected to witness a double digit growth over the next five years, owing to the flourishing pharmaceutical industry, development of healthcare infrastructure, and rising disposable income.

Key players in the drug delivery technologies market are 3M Company (U.S.), Alkermes (Ireland), Aptalis Pharma, Inc. (U.S.), Baxter International, Inc. (U.S.), Becton Dickinson & Co. (U.S.), Catalent Pharma Solutions (U.S.), The Dow Chemical Company (U.S.), Endo Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Nektar Therapeutics (U.S.), SkyePharma PLC (U.K.), and Ypsomed Holding AG (Switzerland).

Buy a copy of this report @

Browse related reports to Biotechnology Market @

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441

Visit MarketsandMarkets Blog @

Connect with us on LinkedIn @

SOURCE MarketsandMarkets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery
2. ResearchMoz: Nanotech Enabled Drug Delivery Therapeutics Market Will be $136 Billion by the Year 2021: Nanotechnology in Drug Delivery: Global Markets
3. Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award
4. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
5. Successful human tests for first wirelessly controlled drug-delivery chip
6. First successful human results achieved: Implantable wireless microchip drug delivery device
7. Floridas Leading Fertility Center Announces Successful Baby Delivery via Egg Freezing
8. New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide With Low Levels of Nitrogen Dioxide for Heart Transplant Patient Evaluation
9. McLean Report on nanotechnology that may enhance medication delivery and improve MRI performance
10. BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
11. Nanotechnology for Drug Delivery: Global Market for Nanocrystals
Post Your Comments:
(Date:11/27/2015)... 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ), ... has closed the sale of its global contrast media ... Euronext) in a transaction valued at approximately $270 million. ... a total of approximately 1,000 employees spread across the ... Louis area. This entire workforce and the ...
(Date:11/26/2015)... England , November 26, 2015 ... innovative medical device company specializing in imaging technologies, announced today ... European Commission as part of the Horizon 2020 European Union ... carry out a large-scale clinical trial in breast cancer. ... (Logo: , --> --> ...
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... of Black Aerospace Professionals (OPBAP) has been formalized with the signing of a ... leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, ...
Breaking Biology Technology:
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
(Date:10/27/2015)... Munich, Germany , ... (ASGM) automatically maps data from mobile eye tracking videos ... so that they can be quantitatively analyzed with SMI,s ... Germany , October 28-29, 2015. SMI,s Automated Semantic ... eye tracking videos created with SMI,s Eye Tracking ...
(Date:10/23/2015)... Research and Markets ( ) has announced the ... 2015-2019" report to their offering. ... recognition biometrics market to grow at a CAGR of ... --> The report, Global Voice Recognition Biometrics ... market analysis with inputs from industry experts. The report ...
Breaking Biology News(10 mins):